That's in animals in 2022. We've seen pretty good pre-clinical data already, but it's results in IPF patients that we won't see til the middle of FY24 now.
It's that part of the phase I that I had really been looking forward to, now it's canceled.
- Forums
- ASX - By Stock
- 1AD
- Ann: AD-214 pathway to IPF efficacy studies
Ann: AD-214 pathway to IPF efficacy studies, page-59
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 1AD (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.48M |
Open | High | Low | Value | Volume |
2.6¢ | 2.6¢ | 2.6¢ | $250 | 9.632K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 107162 | 2.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.6¢ | 670905 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 107162 | 0.025 |
1 | 500000 | 0.024 |
1 | 29010 | 0.023 |
1 | 45450 | 0.022 |
2 | 1047615 | 0.021 |
Price($) | Vol. | No. |
---|---|---|
0.026 | 670905 | 4 |
0.027 | 329171 | 3 |
0.028 | 118518 | 2 |
0.034 | 10000 | 1 |
0.035 | 265260 | 3 |
Last trade - 10.00am 09/07/2024 (20 minute delay) ? |
Featured News
1AD (ASX) Chart |